These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18828499)

  • 1. Immunologic responses to sublingual allergen immunotherapy.
    Akdis M
    Clin Allergy Immunol; 2008; 21():71-86. PubMed ID: 18828499
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
    Jutel M; Akdis M; Blaser K; Akdis CA
    Allergy; 2006 Jul; 61(7):796-807. PubMed ID: 16792576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanisms of allergen-specific immunotherapy more clear].
    Rak S
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1935-7. PubMed ID: 18681375
    [No Abstract]   [Full Text] [Related]  

  • 4. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy.
    Möbs C; Slotosch C; Löffler H; Pfutzner W; Hertl M
    Int Arch Allergy Immunol; 2008; 147(3):171-8. PubMed ID: 18594146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous and sublingual immunotherapy and T regulatory cells: there is clinical relevance.
    Ciprandi G; Morandi F; Olcese R; Silvestri M; Tosca MA
    Clin Exp Allergy; 2010 Oct; 40(10):1578-9; author reply 1579-80. PubMed ID: 20937063
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional regulatory T cells and allergen immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):559-66. PubMed ID: 20859202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic responses to subcutaneous allergen immunotherapy.
    Till SJ; Durham SR
    Clin Allergy Immunol; 2008; 21():59-70. PubMed ID: 18828498
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on mechanisms of allergen injection immunotherapy.
    James LK; Durham SR
    Clin Exp Allergy; 2008 Jul; 38(7):1074-88. PubMed ID: 18691292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Aeroallergen Immunotherapy: Subcutaneous Immunotherapy and Sublingual Immunotherapy.
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):71-86. PubMed ID: 26617228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvants and vector systems for allergy vaccines.
    Moingeon P; Lombardi V; Saint-Lu N; Tourdot S; Bodo V; Mascarell L
    Immunol Allergy Clin North Am; 2011 May; 31(2):407-19, xii. PubMed ID: 21530828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route.
    Mascarell L; Van Overtvelt L; Lombardi V; Razafindratsita A; Moussu H; Horiot S; Chabre H; Limal D; Moutel S; Bauer J; Chiavaroli C; Moingeon P
    Vaccine; 2007 Dec; 26(1):108-18. PubMed ID: 18063445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunotherapy: the quest for innovative adjuvants.
    Goldman M
    Clin Exp Allergy; 2008 Nov; 38(11):1705-6. PubMed ID: 18721252
    [No Abstract]   [Full Text] [Related]  

  • 14. Allergen-specific immunotherapy: regulatory T cells or allergen-specific IgG?
    Kündig TM; Bachmann MF
    Hum Vaccin; 2010 Aug; 6(8):673-5. PubMed ID: 20523122
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerance induced by allergen immunotherapy.
    Plaut M; Rotrosen D
    Clin Allergy Immunol; 2004; 18():681-702. PubMed ID: 15042942
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomarkers for allergen immunotherapy in cedar pollinosis.
    Fujisawa T; Nagao M; Hiraguchi Y; Hosoki K; Tokuda R; Usui S; Masuda S; Shinoda M; Hashiguchi A; Yamaguchi M
    Allergol Int; 2009 Jun; 58(2):163-70. PubMed ID: 19390237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual immunotherapy and regulatory T cells.
    Ciprandi G; Fenoglio D; Cirillo I; Milanese M; Minuti P
    Allergy; 2006 Apr; 61(4):511-3. PubMed ID: 16512819
    [No Abstract]   [Full Text] [Related]  

  • 19. Sublingual immunotherapy: dosing in relation to clinical and immunological efficacy.
    Larenas-Linnemann DE
    Allergy Asthma Proc; 2008; 29(2):130-9. PubMed ID: 18430309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual vaccines based on wild-type recombinant allergens.
    Van Overtvelt L; Razafindratsita A; St-Lu N; Didierlaurent A; Batard T; Lombardi V; Martin E; Moingeon P
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):247-9. PubMed ID: 17124785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.